Date: May 6-7, 2025
Location: The Hyatt Regency, Boston, Massachusetts
Details: Panitch Schwarze attorneys Travis W. Bliss, Ph.D. and Erin M. Dunston will discuss life sciences patent proceedings during the 7th Annual Life Sciences Patent Network (LSPN) North America–Spring Conference, an event co-sponsored by the firm. The session is titled “Best Practices: Post-Grant Proceedings in the U.S. and EPO.” Bliss and Dunston will be joined by Emily Hayes of Mewburn Ellis.
The discussion will focus on patent filing and prosecution for post-grant proceedings at the United States Patent and Trademark Office (USPTO) and the European Patent Organisation (EPO). Participants will provide an overview of recent happenings regarding patent procedures and important considerations for navigating defensive and offensive strategies.
Bliss assists clients throughout the entire IP process, from strategy development, counseling, and opinions; to procurement of appropriate IP rights (patents, trademarks, trade secrets); to monetization of those assets through development and implementation of effective IP licensing strategies; and, finally, to enforcing, defending, and challenging IP rights through litigations in court and before the USPTO. His technology focus is largely on the life sciences, animal and plant health and genetics, agriculture, horticulture, and cannabis industries.
Dunston focuses her practice on patent procurement, opinions, enforcement (both in district courts and before the Patent Trial and Appeal Board), and portfolio strategy. With clients ranging from individual inventors to large, multi-national companies, she tailors her approach to each client’s goals. Dunston’s matters are primarily in the life science space (small molecules, large molecules, and medical devices), but she has handled projects on subject matter ranging from precipitated silica to vaccines to radiotherapy devices.
Organized by Life Sciences Intellectual Property Review, LSPN North America Spring 2025 gathers professionals from the intricate world of life sciences IP. Participants share cutting-edge insights into IP challenges in the pharmaceutical, biotechnology, and medical technology industries.
Click here to register for LSPN North America Spring 2025.